CSPC Pharmaceutical Group Limited (CVG) — Free Cash Flow Generation Index
CSPC Pharmaceutical Group Limited (CVG) has a Free Cash Flow Generation Index of 1.12x as of September 2020. Free cash flow of €2.41 Billion represents 1% of operating cash flow (€2.16 Billion). See working capital position of CSPC Pharmaceutical Group Limited to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
CSPC Pharmaceutical Group Limited Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for CSPC Pharmaceutical Group Limited across 13 annual periods. Explore cash flow to debt ratio of CSPC Pharmaceutical Group Limited to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year Free Cash Flow Generation Index for CSPC Pharmaceutical Group Limited. For the full company profile including market capitalisation, see market cap of CSPC Pharmaceutical Group Limited.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | €3.55 Billion | €5.83 Billion | €2.28 Billion | ▲ +48.8% |
| 2024 | 0.41x | €1.86 Billion | €4.53 Billion | €2.68 Billion | ▼ -25.2% |
| 2023 | 0.55x | €2.29 Billion | €4.18 Billion | €1.89 Billion | ▼ -14.9% |
| 2022 | 0.64x | €4.90 Billion | €7.63 Billion | €2.22 Billion | ▲ +3.6% |
| 2021 | 0.62x | €2.88 Billion | €4.64 Billion | €1.41 Billion | ▼ -19.0% |
| 2020 | 0.77x | €5.16 Billion | €6.74 Billion | €1.36 Billion | ▲ +74.5% |
| 2019 | 0.44x | €1.66 Billion | €3.78 Billion | €1.88 Billion | ▼ -2.9% |
| 2018 | 0.45x | €1.72 Billion | €3.80 Billion | €1.67 Billion | ▼ -14.0% |
| 2017 | 0.53x | €1.73 Billion | €3.29 Billion | €1.18 Billion | ▼ -61.5% |
| 2016 | 1.36x | €3.98 Billion | €2.92 Billion | €1.06 Billion | ▲ +0.1% |
| 2015 | 1.36x | €3.06 Billion | €2.25 Billion | €815.69 Million | ▼ -5.8% |
| 2014 | 1.45x | €2.61 Billion | €1.81 Billion | €807.00 Million | ▼ -16.5% |
| 2013 | 1.73x | €1.41 Billion | €814.86 Million | €597.12 Million | — |